BSEBoard Meeting6d ago · 4 Nov 2026, 03:42 pm
Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Approval of Unaudited Financials for Q and half year ended 30th September 2026
Sandu Pharmaceuticals Ltd · 524703
✦ AI SummaryResults
Sandu Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/11/2026 to consider and approve the Unaudited Financials for Q and half year ended 30th September 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Intimation for Approval Of Unaudited Financials For Quarter And Half Year Ended 30Th September 2026
Attachments (1)
📄pdf
Download →
24d769fd-5c78-4014-a9a3-08fbaf06b013.pdf
View document text
N SANDU PHARMACEUTICALS LIMITED
CIN:L24233GA1985PLC001587
SAMDU
m Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511.
Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in
Ref No: SPL/Corp.Sec/2026-27/506
Dated:04/11/2026
Department of Corporate Services
Bombay Stock Exchange Limited,
Phirojshah Jeejobhoy tower,
Dalal Street,
Mumbai-400001.
Sub: Intimation about Board Meeting 29 & 30 of SEBI (Listing Obligation and
Disclosure Requirements) Regulation 2015
ScripCode:524703
Respected Sir
We would like to inform you that a Meeting of the Board of Directors of the
Company will be held on Saturday, the 14th day of November 2026 at 04:00 p.m at
the Corporate Office of the Company at Sandu Pharmaceuticals Limited, Sandu
Nagar, D K Sandu Marg, Chembur, Mumbai 400 071 to consider the following
O To consider and approve the Standalone Unaudited Financial Results of the
Company for the quarter ended 30th September, 2026.
O To consider any other matter with the permission of the Chair.
This notice is being submitted pursuant to Regulation 29 of the Securities &
Exchange Board of India (Listing Regulations and Disclosure Requirements)
Regulation 2015.
In Compliance with the Company’s Code of Conduct for prevention of Insider
Trading devised as per the SEBI (Prohibition of Insider Trading) we would also
like to inform that the trading window for dealing in the Securities of the Company
has been closed for the Company’s Directors/Officer and designated employees of
the Company from the opening of Trading hours on Thursday, 01t day of October
2026 till 48 hours after announcement of financial results to public for the Quarter
ended 30" September 2026 in compliances with the code of conduct for
prevention of Insider Trading Regulation 2015.
You are requested to kindly take note of the same.
Thanking you,
Yours Faithfully,
FOR SANDU PHARMACEUTICALS LIMITED.
Pratika Mhambray
Company Secretary & Compliance Officer
A:36512
AN 1SO 9001:2015 CERTIFIED ORGANISATION
Corporate Office: P B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai - 400 071
Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in